Bellicum Pharmaceuticals, Inc. (BLCM): Price and Financial Metrics
BLCM Price/Volume Stats
| Current price | $0.07 | 52-week high | $1.31 |
| Prev. close | $0.08 | 52-week low | $0.06 |
| Day low | $0.07 | Volume | 6,000 |
| Day high | $0.09 | Avg. volume | 22,874 |
| 50-day MA | $0.11 | Dividend yield | N/A |
| 200-day MA | $0.29 | Market Cap | 726.83K |
BLCM Stock Price Chart Interactive Chart >
Bellicum Pharmaceuticals, Inc. (BLCM) Company Bio
Bellicum Pharmaceuticals is a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies for various forms of cancer, including hematological cancers and solid tumors, as well as orphan inherited blood disorders. The company was founded in 2004 and is based in Houston, Texas.
BLCM Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | -68.75% |
| 3-year | -95.93% |
| 5-year | -99.19% |
| YTD | -53.33% |
| 2023 | -79.17% |
| 2022 | -51.68% |
| 2021 | -57.79% |
| 2020 | -72.64% |
| 2019 | -55.82% |
Continue Researching BLCM
Want to see what other sources are saying about Bellicum Pharmaceuticals Inc's financials and stock price? Try the links below:Bellicum Pharmaceuticals Inc (BLCM) Stock Price | Nasdaq
Bellicum Pharmaceuticals Inc (BLCM) Stock Quote, History and News - Yahoo Finance
Bellicum Pharmaceuticals Inc (BLCM) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...